Application of the ApcMin/+ mouse model for studying inflammation-associated intestinal tumor

作者: Lu Wang , Qingzhu Zhang

DOI: 10.1016/J.BIOPHA.2015.02.023

关键词:

摘要: Abstract Chronic inflammatory diseases of the intestinal tract have been known to increase risk developing a form colorectal cancer as inflammation-associated cancer. The roles inflammation in tumor formation and development ApcMin/+ mice broadly corroborated. mouse model contains point mutation adenomatous polyposis coli (Apc) gene only develops precancerous lesions, benign adenomas. Thus, it provides an excellent vivo system investigate molecular events involved process which may contribute multistep tumorigenesis carcinogenesis. Recent investigations that employ this studied effects alterations, microorganisms, drugs, diet, exercise sleep on development, revealed mechanisms formation, promotion carcinogenesis adenomas with background inflammation. Herein, we focus our review application for studying find anti-inflammation is possible strategy combating tumor, but sometimes cannot help reduce burden. Moreover, various inflammation-related genes are different mechanistic stages intricate regulatory exist whole progression tumor.

参考文章(69)
Simone Manfredelli, Vincenzo Urbano, Giovanni Leonetti, Rita De Sanctis, Marcello Bezzi, Angelo Forte, Dietary chemoprevention of colorectal cancer Annali Italiani Di Chirurgia. ,vol. 79, pp. 261- 267 ,(2008)
Liying Yang, Zhiheng Pei, Bacteria, inflammation, and colon cancer World Journal of Gastroenterology. ,vol. 12, pp. 6741- 6746 ,(2006) , 10.3748/WJG.V12.I42.6741
Jamie L. McClellan, J. Mark Davis, Jennifer L. Steiner, Reilly T. Enos, Seung H. Jung, James A. Carson, Maria M. Pena, Kevin A. Carnevale, Franklin G. Berger, E. Angela Murphy, Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 303, ,(2012) , 10.1152/AJPGI.00252.2012
Beatriz Stransky, Sandro J. de Souza, Modeling tumor evolutionary dynamics. Frontiers in Physiology. ,vol. 3, pp. 480- 480 ,(2013) , 10.3389/FPHYS.2012.00480
Shuh Narumiya, Hiroshi Seno, Masanobu Oshima, Hiroko Oshima, Tomo-o Ishikawa, Tsutomu Chiba, Makoto M. Taketo, Kazuaki Takaku, Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps Cancer Research. ,vol. 62, pp. 506- 511 ,(2002)
Giovanni Monteleone, Massimo Claudio Fantini, Francesco Pallone, Angelamaria Rizzo, Intestinal inflammation and colorectal cancer: A double-edged sword? World Journal of Gastroenterology. ,vol. 17, pp. 3092- 3100 ,(2011) , 10.3748/WJG.V17.I26.3092
Lu Wang, Yan Wang, Zhiyu Song, Jiahui Chu, Xianjun Qu, Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development Journal of Interferon & Cytokine Research. ,vol. 35, pp. 273- 280 ,(2015) , 10.1089/JIR.2014.0132
Hiroyuki Kohno, Mami Takahashi, Yumiko Yasui, Rikako Suzuki, Shingo Miyamoto, Yoshihisa Kamanaka, Masao Naka, Takayuki Maruyama, Keiji Wakabayashi, Takuji Tanaka, A specific inducible nitric oxide inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in maleApcMin/+ mice International Journal of Cancer. ,vol. 121, pp. 506- 513 ,(2007) , 10.1002/IJC.22736
H. Shaked, L. J. Hofseth, A. Chumanevich, A. A. Chumanevich, J. Wang, Y. Wang, K. Taniguchi, M. Guma, S. Shenouda, H. Clevers, C. C. Harris, M. Karin, Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 109, pp. 14007- 14012 ,(2012) , 10.1073/PNAS.1211509109
Ibrahim Altamemi, E Angela Murphy, James F Catroppo, Elizabeth E Zumbrun, Jiajia Zhang, Jamie L McClellan, Udai P Singh, Prakash S Nagarkatti, Mitzi Nagarkatti, None, Role of microRNAs in Resveratrol-Mediated Mitigation of Colitis-Associated Tumorigenesis in ApcMin/+ Mice Journal of Pharmacology and Experimental Therapeutics. ,vol. 350, pp. 99- 109 ,(2014) , 10.1124/JPET.114.213306